Susceptibility of alpha-1 antitrypsin deficiency variants to polymer-blocking therapy

Riccardo Ronzoni(University College London), David A. Lomas(University of Cambridge)

JCI Insight

July 8, 2025

10.1172/jci.insight.194354

Cited by 4

Related Papers

Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease

|UCL Discovery (University College London)|2022|32

The molecular species responsible for α<sub>1</sub>‐antitrypsin deficiency are suppressed by a small molecule chaperone

|FEBS Journal|2020|22